News
Poster about Palonosetron is finalist in Paris
During the ISPOR (International Society for Pharmacoeconomics and Outcomes Research) 12th Annual European Congress, in Paris, October 2009, one of the posters presented by Evidencias was considered for an award. The theme was Two different doses of Palonosetron (PAL) for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoH) treatment: systematic review (SR) and meta-analysis (MA).
.